Researchers identify gene set that shows which patients benefit from chemo after surgery

Wednesday, September 8, 2010 - 06:28 in Health & Medicine

Lung cancer researchers have identified a genetic signature that can help doctors determine which patients with early-stage non-small cell lung cancer are at high risk for developing disease recurrence and therefore may benefit from chemotherapy after surgery ('adjuvant chemotherapy')...

Read the whole article on

More from

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net